Apogee Therapeutics · 1 week ago
Vice President, Inflammatory and Immune Disease Biomarker Development
United States
Full-time
Hybrid
Director/Executive
$320K/yr - $355K/yr
15+ years expApogee Therapeutics, founded in 2022, is a biotechnology company focused on developing biologics for inflammatory and immune diseases. They are seeking a Vice President to lead biomarker development efforts, particularly in late-stage clinical development, and to oversee the strategy and implementation of their biomarker programs.
BiotechnologyLife ScienceMedicalTherapeutics
Responsibilities
Lead the strategic planning and execution of biomarker discovery and development programs for inflammatory and immunology diseases, focusing on atopic dermatitis, asthma, COPD and EOE and particularly late-stage clinical development
Develop and articulate the late-stage clinical and post-launch strategic vision for the biomarker programs to internal and external stakeholders
Collaborate with internal and external stakeholders to integrate our biomarker discovery and development efforts into our development programs, including clinical trials and BLAs
Oversee the Biomarker Discovery and Development team to drive efforts through a combination of in vitro/in vivo and in silico data analyses, in house and in collaboration with external partners
Together with the Senior Director-Biomarker Discovery and Development develop and implement biomarker strategies to demonstrate the clinical utility of novel biomarkers and the distinction of patient populations and responders as well as additional indications
Stay current on emerging trends and technologies in biomarker discovery and development, and implement best practices to ensure the success of our programs
Provide strategic input and leadership to cross-functional program and functional teams to drive the development of novel, innovative therapies for inflammatory and immunology diseases
Qualification
Required
PhD or MD in a relevant scientific discipline
At least 15 years of track-record in senior leadership roles in biomarker discovery and development
Proven success in leading biomarker discovery programs from ideation to clinical validation
Focused understanding on late-stage clinical development including Phase 3 trials with biologics and BLAs
Excellent communication skills and ability to articulate and communicate complex strategic vision with a variety of internal and external stakeholders
Deep hands-on knowledge of the antibody development process and regulatory requirements for biomarkers in clinical trials and for BLA-submissions
Expertise in collaborating with external partners and key opinion leaders in the field of inflammatory and immunology diseases
Strong leadership and communication skills fully aligned with our C.O.R.E. values
Ability to effectively lead your internal team and fully integrate this team from early- to late-stage clinical development efforts
Position requires up to 30% travel including mandatory in-person attendance at All Hands meetings typically held twice per year as well as travel to Apogee offices in Boston and San Francisco
Preferred
Experience in I&I, atopic dermatitis, asthma, COPD and/or EOE a plus
Strong preference for candidates with late stage clinical and post launch experience
Benefits
Market competitive compensation and benefits package, including base salary, performance bonus, equity grant opportunities, health, welfare & retirement benefits
Competitive time off, including three weeks PTO, two one-week company-wide shutdowns a year and dedicated paid sick leave
Commitment to growing you professionally and providing access to resources to further your development
Regular all team, in-person meetings to build relationships and problem solve
Company
Apogee Therapeutics
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
201-500 employees
H1B Sponsorship
Apogee Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
Funding
Current Stage
Public CompanyTotal Funding
$997M2025-10-08Post Ipo Equity· $345M
2024-03-07Post Ipo Equity· $483M
2023-07-13IPO
Leadership Team
Nimish Shah
Co-Founder & Board Director
Jane Pritchett Henderson
Chief Financial Officer
Recent News
2026-01-22
2026-01-06
Company data provided by crunchbase